Metraipolis › archive › dc_1cc28385f44d
Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials — Europe PMC PMID:42285001
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42285001
- DOI
- 10.1016/j.breast.2026.104820
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T04:27:41.523Z
- SHA-256 of the archived text
2aa006f6985e47905331bbd33149533c973bdcbc37581b125a64456b133b6bfb- Stable URL of this page
https://metraipolis.com/documento/dc_1cc28385f44d
How to cite
Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials — Europe PMC PMID:42285001 — Europe PMC (en), https://europepmc.org/article/MED/42285001 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1cc28385f44d (Metraipolis archive dc_1cc28385f44d, sha256 2aa006f6985e47905331bbd33149533c973bdcbc37581b125a64456b133b6bfb)
BibTeX
@misc{dc1cc28385f44d,
title = {Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials — Europe PMC PMID:42285001},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42285001},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1cc28385f44d; sha256 2aa006f6985e47905331bbd33149533c973bdcbc37581b125a64456b133b6bfb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42285001. Agents can read the archived copy with the MCP tool read_document.